Lilly, Amylin confirm four more deaths linked to Byetta

08/26/2008 | Wall Street Journal, The · San Diego Union-Tribune

Amylin Pharmaceuticals and Eli Lilly and Co. publicly disclosed the deaths of four patients using Byetta to address concerns about the diabetes drug's safety. An FDA announcement last week mentioned six cases -- including two deaths -- of acute pancreatitis linked to the treatment. But the companies said they had told the FDA about the four deaths, which are in addition to the six cases reported.

View Full Article in:

Wall Street Journal, The · San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC